BioStem Technologies (BioStem Technologies) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Price-to-Operating-Cash-Flow?

As of today (2024-06-06), BioStem Technologies's share price is $7.66. BioStem Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.05. Hence, BioStem Technologies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for BioStem Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, BioStem Technologies's highest Price-to-Operating-Cash-Flow Ratio was 750.00. The lowest was 23.06. And the median was 50.00.

BSEM's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.87
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

BioStem Technologies's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.05.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BioStem Technologies was -186.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 37.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 38.80% per year.

During the past 13 years, BioStem Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.80% per year. The lowest was -19.60% per year. And the median was 39.85% per year.

BioStem Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioStem Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Price-to-Operating-Cash-Flow Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															29.03	61.29	-	-	-

Competitive Comparison of BioStem Technologies's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, BioStem Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioStem Technologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's Price-to-Operating-Cash-Flow falls into.

BioStem Technologies Price-to-Operating-Cash-Flow Calculation

BioStem Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	7.66	/	-0.053
	=

BioStem Technologies's Share Price of today is $7.66.
BioStem Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioStem Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.